Cancer Symposium 2017
Friday, September 15, 2017, 5–8:30 p.m.
Hyatt Regency Monterey, Monterey, California
Symposium and dinner: $50
Precision medicine: Promise and complexity in primary and specialty care
A new paradigm in disease classification, diagnosis, and treatment is rapidly expanding. Known as precision medicine, it integrates genetic information, microbiome data, and information on patients' environment and lifestyle to better identify and classify disease processes and provide therapeutic solutions. It does not literally mean the creation of drugs or medical devices unique to each patient, but rather the ability to classify individuals into subpopulations that differ in their susceptibility to a particular disease, in the biology or prognosis of diseases they may develop, or in their response to a specific treatment.
Faculty from UCSF's Helen Diller Family Comprehensive Cancer Center and physicians from our community will discuss how doctors can use precision medicine in the most efficient, effective ways for their daily practice.
About the speakers
W. Michael Korn, MD, initiated and chairs the UCSF Molecular Tumor Board and has strong clinical and research interests in precision oncology. He is principal investigator on clinical trials of novel and anti-cancer agents as part of the Phase 1 Clinical Trials program and is an expert in gastrointestinal cancers.
M. Zach Koontz, MD, joined the practice of Pacific Cancer Care in Monterey after his residency and fellowship at Stanford University. He is a graduate of UC Irvine's School of Medicine and completed his undergraduate degree at Santa Clara University. He is board certified in both medical oncology and hematology.
Daniel G. Luba, MD, serves as managing partner of Gastroenterology Consultants and the Monterey Bay Endoscopy Center. Dr. Luba founded Project DNA, whose mission is to educate the community and doctors about hereditary cancer syndromes, set up systematic screening programs throughout Monterey County, and provide long-term follow-up care.